Central neurons respond to synaptic inputs from other neurons by generating synaptic potentials. Once the summated synaptic potentials reach threshold for action potential firing, the signal propagates leading to transmitter release at the synapse. The calcium influx accompanying such signaling opens calcium-activated ion channels for feedback regulation. Here, we report a mechanism for modulating hippocampal neuronal signaling that involves calcium-activated chloride channels (CaCCs). We present evidence that CaCCs reside in hippocampal neurons and are in close proximity of calcium channels and NMDA receptors to shorten action potential duration, dampen excitatory synaptic potentials, impede temporal summation, and raise the threshold for action potential generation by synaptic potential. Having recently identified TMEM16A and TMEM16B as CaCCs, we further show that TMEM16B but not TMEM16A is important for hippocampal CaCC, laying the groundwork for deciphering the dynamic CaCC modulation of neuronal signaling in neurons important for learning and memory.
INTRODUCTION
Neuronal signaling is subject to feedback regulation by ion channels. A neuron integrates impinging synaptic inputs to generate action potentials for signal transmission to the next neuron; it conveys information by adjusting the action potential number, the ''firing frequency,'' or timing, the ''firing pattern.'' As action potential triggers transmitter release from axon terminals, the ensuing transmitter receptor activation leads to synaptic responses. Ca 2+ signals generated during action potential and synaptic potentials activate Ca 2+ -activated ion channels thereby providing feedback regulation.
Besides voltage-activated Na + and K + channels that make up the basic machinery for action potential generation (Hodgkin and Huxley, 1952) -activated K + channels (BK) to modulate action potential waveform (Adams et al., 1982; Lancaster and Nicoll, 1987; Storm, 1987a Storm, , 1987b , leading to regulation of transmitter release from axon terminals (Hu et al., 2001; Lingle et al., 1996; Petersen and Maruyama, 1984; Raffaelli et al., 2004; Robitaille et al., 1993) and firing patterns in the soma (Madison and Nicoll, 1984; Shao et al., 1999) .
As to transmitter activation of glutamatergic a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) and N-methyl D-aspartate receptors (NMDA-Rs), NMDA-Rs mediate Ca 2+ influx which activates small-conductance Ca 2+ -activated K + channels (SK) (Fakler and Adelman, 2008) to influence synaptic plasticity (Lin et al., 2008; Ngo-Anh et al., 2005; Stackman et al., 2002) ; SK activation during an excitatory postsynaptic potential (EPSP) reduces the synaptic response and the likelihood for long-term potentiation (LTP) (Hammond et al., 2006; Stackman et al., 2002) . Whether and how Ca 2+ -activated Cl À channels (CaCCs) might be involved in neuronal signaling is currently unknown. Even the basic question regarding the existence of CaCCs in hippocampal pyramidal neurons has yet to be addressed, notwithstanding earlier studies of CaCCs in anterior pituitary neurons (Korn et al., 1991) , amygdala neurons (Sugita et al., 1993) , and cingulate cortical neurons (Higashi et al., 1993) . The paucity of information regarding CaCCs in central neurons is partly due to the uncertainty regarding their molecular identity. Now that three independent studies reached the same conclusion that TMEM16A of a family of transmembrane protein with unknown functions encodes a CaCC (Caputo et al., 2008; Schroeder et al., 2008; Yang et al., 2008 )-a conclusion verified by reports that the native CaCC current in several cell types is eliminated in TMEM16A knockout mice (Ousingsawat et al., 2009; Romanenko et al., 2010) and TMEM16A is important for vasoconstriction (Manoury et al., 2010) , Ca 2+ -dependent Cl À transport across airway epithelia , rhythmic contraction in gastrointestinal tracts (Huang et al., 2009; Hwang et al., 2009) , and fluid excretion in salivary glands (Romanenko et al., 2010) . Moreover, TMEM16B also gives rise to CaCC (Pifferi et al., 2009; Schroeder et al., 2008) , likely accounting for the CaCC in olfactory sensory neurons (Billig et al., 2011; Stephan et al., 2009 ) and photoreceptor terminals (Barnes and Hille, 1989; Stö hr et al., 2009) .
In this study, we show CaCCs are present in hippocampal neurons and serve functions important for neuronal signaling. CaCC activation by Ca 2+ influx through NMDA receptors reduces the EPSP and the extent of temporal summation. CaCC also elevates the threshold for spike generation by excitatory synaptic potentials so as to further dampen EPSP-spike coupling. Ca 2+ influx through Ca 2+ channels that open during an action potential activates CaCC to modulate spike duration in the somatodendritic region. Likely encoded by TMEM16B rather than TMEM16A, CaCCs reside in the vicinity of voltage-gated Ca 2+ channels to regulate spike duration and in close proximity of NMDA receptors to modulate excitatory synaptic responses; both forms of regulation are eliminated by internal BAPTA but not EGTA.
RESULTS
Activating Voltage-Gated Ca 2+ Channels by Depolarizing
Hippocampal Pyramidal Neurons Induces a Tail Current that Is Carried by Cl -Ions Activation of voltage-gated Ca 2+ channels can lead to CaCC activation in smooth muscle and sensory neurons (Frings et al., 2000; Scott et al., 1995) . To look for CaCC in hippocampal current followed by a tail current that reverses at E Cl as in the case of cultured neurons: À45 ± 0.5 mV (n = 25 for 10 recordings from cultured neurons and 15 from acute slices) (E Cl = À46.8 mV). The tail (left) is sensitive to the CaCC blocker NFA (300 mM) (middle). The dashed line in (A) and (D) indicates zero current. See Figure S1A for time course plot. The error bars are standard error of the mean (SEM).
neurons, we applied a 200 ms depolarization step from À70 mV to 0 mV to activate voltage-gated Ca 2+ channels. This depolarizing prepulse resulted in Ca 2+ influx due to the large inward Ca 2+ current, and was followed by a tail current (arrow, Figure 1A ) that reversed near the equilibrium potential of Cl À ions (E Cl ) ( Figure 1A , right), in cultured pyramidal neurons at DIV (days in vitro) 14 and also in CA1 pyramidal neurons of acute slices from P14-21 (postnatal day 14-21) mice. Only Ca 2+ and Cl À ions are possible charge carriers in these experiments because (1) Na + was replaced by NMDG and Na + channels were blocked by tetrodotoxin (TTX) and (2) K + ions were removed and K + channels were blocked with Cs + and tetraethylamonium (TEA) in the internal solution and 4-aminopyridine (4AP) in the external solution, which also included the GABA A receptor antagonist picrotoxin ( Figure 1A ). So we went on to test whether Ca 2+ influx through Ca 2+ channels activates Cl À channels to generate the tail current.
To verify that Cl À is the ion carrier for the tail current, we determined its reversal potential in three different internal Cl À concentrations. The voltage steps following the prepulse depolarization ranged from À100 mV to À25 mV (5 or 10 mV steps).
After subtracting the background current elicited without a depolarization prepulse (À70 mV holding potential without 0 mV depolarization prepulse) from the tail current elicited with a depolarization prepulse (to 0 mV), we plotted the average tail current measured at 150-200 ms after the end of the 0 mV prepulse as a function of voltage to determine the reversal potential ( Figure 1B ). We found that the reversal potential, plotted as a function of log 10 [Cl À ] in , followed the Nernst equation with a slope of 58 mV ( Figure 1C ). These results reveal that this tail current is a Cl À current.
The Tail Current Is Activated by Ca
2+
To verify that this tail Cl À current is activated by Ca 2+ , first we eliminated Ca 2+ current with 100 mM Cd 2+ ( Figure 2A ) and found the tail Cl À current absent ( Figure 2A ). By including 10 mM BAPTA in the whole-cell patch pipette solution to chelate Ca 2+ , we found that the tail current was nearly abolished ( Figure 2B ). Moreover, replacing external Ca 2+ with Ba 2+ ( Figure 2C ) also eliminated the tail current ( Figure 2C ). These experiments demonstrate that the tail current requires internal Ca 2+ for activation. Figure S1C for time course plot.
(D) Tail current diminishes in amplitude as prepulse voltage approaches E Ca (>+ 100 mV) (n = 52).
(E) Tail current increases with increasing duration of prepulse to 0 mV (n = 22, p < 0.01) but not + 100 mV (n = 22, p = 0.9). The error bars are SEM.
To test whether prepulse depolarization to levels approaching the equilibrium potential of Ca 2+ (E Ca ) results in smaller tail current due to the diminishing driving force for Ca 2+ , we varied the prepulse from À70 mV (no depolarization) to +100 mV and measured the tail current ( Figure 2D ). Indeed, whereas Ca 2+ influx was minimal at prepulse potentials more negative than À30 mV due to insufficient activation of Ca 2+ channels and consequently there was little tail current, the tail current grew with further depolarization and reached a maximum near 0 mV prepulse, and then diminished as the prepulse depolarization approached E Ca (calculated to be > 100 mV).
We next test whether prolonging the prepulse depolarization to increase the Ca 2+ influx increases the tail current. While the tail current in response to longer prepulse to 0 mV was larger ( Figure 2E , white bars), it remained unchanged for prepulse to +100 mV regardless of the duration ( Figure 2E , black bars). These experiments show that the tail current is a Ca 2+ -activated Cl À current.
CaCC Blockers Dose Dependently Reduce the Tail Current and Broaden the Action Potential in Hippocampal Pyramidal Neurons Next, we tested two classical CaCC blockers, niflumic acid (NFA) and 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB).
Whereas depolarization from À70 mV to 0 mV resulted in an inward Ca 2+ current followed by a tail current (tail current measured at À90 mV, E Cl = -46.8 mV), both CaCC blockers reduced the tail current ( Figure 3A ) while leaving the peak Ca 2+ current intact.
As shown in Figure 1D for recording from acute slices at 35 C with 2.5 mM external Ca 2+ , depolarization to 0 mV for one millisecond induced the CaCC tail current that reversed at E Cl . We therefore tested whether CaCC can modulate spike waveform by injecting a 2 ms pulse of current to depolarize neurons in hippocampal slices at 35 C to barely reach the threshold for -Activated Cl -Current in Hippocampal Pyramidal Neurons Is Sensitive to Two Different CaCC Blockers and Is Important for Controlling Action Potential Duration (A) CaCC is significantly reduced to 28% ± 5.1% of control by 100 mM NFA (top left, n = 9, p < 0.001) and to 18% ± 5.9% of control by 100 mM NPPB (top right, n = 10, p < 0.001). IC 50 is 33 ± 2.3 mM for NFA (bottom left, n = 5) and 26.2 ± 1.36 mM for NPPB (bottom right, sequentially increasing blocker concentration at room temperature, n = 5). The membrane voltage was held at À70 mV, depolarized to 0 mV to induce Ca 2+ influx and repolarized back to spike generation $90% of the time, and looked for the effect of NFA and NPPB. The resting membrane potential ranged from À65 mV to À70 mV in all our experiments, and we injected a small amount of hyperpolarizing current to bring the membrane potential to À70 mV at the start of the experiment. Indeed, 100 mM NFA caused spike broadening ( Figure 3B , top); there was a dose-dependent increase of the spike width (measured at 33% of the spike height) with the maximal spike widening corresponding to an increase by $65% of the control spike width ( Figure 3B, bottom) . Similar results were obtained with a second CaCC blocker, NPPB ( Figure 3C ).
The spike broadening following application of 100 mM NFA was reversible upon washout (see Figure S2A available online; see Figure S1 for time course plots of drug effects). When we shifted E Cl from À70 mV to +54 mV by changing internal and external Cl À concentrations, 100 mM NFA narrowed the spike width instead ( Figure S2B ). Importantly, with 10 mM internal BAPTA to chelate Ca 2+ and prevent CaCC activation, the spike duration was unaffected by NFA ( Figure S2C ). In these and all following studies, the CaCC blockers had no significant effects on the resting membrane potential or input resistance of hippocampal neurons. These controls verify that the observed NFA effect is specific for CaCC, thereby providing support for our conclusion that CaCC controls action potential repolarization.
TMEM16B Is Expressed in the Hippocampus
To explore the molecular identity of the hippocampal CaCC, we performed RT-PCR and found TMEM16B but not TMEM16A transcript in cultured hippocampal neurons ( Figure 4A ). In situ hybridization further revealed that the TMEM16B mRNA is present in CA1 and CA3 pyramidal neurons, dentate granule cells and hilar interneurons of the hippocampus ( Figure 4G ). We next asked whether the TMEM16B protein is also expressed in the hippocampus, by raising a rabbit polyclonal antibody against an epitope in a putative extracellular loop of mouse TMEM16B. The antibody readily detected TMEM16B-mCherry (monomer $132 kDa) expressed in HEK293 cells, but not in control cells cotransfected with enzymatically prepared small interfering RNA (esiRNA) (Kittler et al., 2005) targeting TMEM16B ( Figure S3B ). Using this rabbit anti-TMEM16B antibody to probe for the endogenous TMEM16B, we detected a band migrating at the expected size of TMEM16B ($105 kDa) in cultured mouse hippocampal neurons ( Figure 4H ). These studies reveal that TMEM16B is expressed in the hippocampus.
shRNA Knockdown of TMEM16B Reduces CaCC and Retards Action Potential Repolarization in Hippocampal Pyramidal Neurons To test for the involvement of TMEM16B in hippocampal CaCC, we cloned two independent small hairpin RNAs (shRNAs) targeting different parts of the TMEM16B mRNA, 16B-shRNAs #2 and #5, as well as a scrambled control shRNA into a lentiviral transfer vector that contains the coding sequence for green fluorescence protein (GFP). These TMEM16B-shRNAs reduced the expression of TMEM16B-mCherry fusion proteins in HEK293 cells ( Figure S3C ) as well as endogenous TMEM16B mRNA in cultured hippocampal neurons 10 days after lentivirus infection ( Figure 4B ). Whereas these infected neurons displayed normal Ca 2+ current, shRNA #2 or shRNA #5 knockdown of TMEM16B reduced the tail current amplitude by 60% ± 4.5% and 61% ± 5%, respectively, 12 days after infection ( Figures  4C and 4D ). Significant reduction of the tail current was also observed at 9 and 10 days after infection ( Figure 4D ). In contrast, comparison of CA1 pyramidal neurons in hippocampal slices from wild-type (n = 7) and TMEM16A KO mice (n = 11) revealed no significant difference in the tail current (109% ± 9% of control with 0 mV prepulse, p = 0.9) ( Figure S3A ), indicating that TMEM16B but not TMEM16A is required for the CaCC in hippocampal pyramidal neurons. Knockdown of TMEM16B by shRNA #2 or shRNA #5, but not the scrambled control RNA, lengthened the action potential duration by 50% ± 7.6% and 40% ± 5.2% respectively; the action potential broadening was evident starting at 9 days after infection, as well as 10 and 12 days after infection (Figures 4E). We further tested the effect of shRNA knockdown of TMEM16B by performing whole-cell recording of CaCC elicited by raising intracellular Ca 2+ in the patch pipette solution from 0 to 0.5 mM Ca 2+ , and found $80% reduction of CaCC current 10 days after lentivirus infection ( Figure 4F ). These studies indicate that TMEM16B is important for hippocampal CaCC that regulates the spike waveform.
CaCC Shortens Action Potentials in CA3 Pyramidal
Neurons without Affecting Transmitter Release from Their Axon Terminals Blocking CaCC caused spike broadening in CA1 and CA3 pyramidal neurons recorded at 35 C (Figures 3B and 5A) and room temperature ( Figure S4 ), and the spike broadening persisted in the presence of 100 mM calcium/calmodulin activated kinase II (CaMKII) inhibitor KN62 ( Figure S4 ). Whereas 10 mM internal BAPTA prevented CaCC activation following the opening of Ca 2+ channels ( Figures S2C and 4A ), 100 mM NFA still caused spike broadening when 10 mM EGTA was included in the internal solution ( Figure S4A ), indicating that CaCCs are in close vicinity of voltage-gated Ca 2+ channels.
We next asked whether CaCC also affects spike duration in the axon terminals. If so, applying CaCC blocker should increase transmitter release from CA3 axon terminals that form synapses with CA1 neurons. First, we performed field recording of the pharmacologically isolated AMPA-fEPSP in the CA1 dendritic field, while stimulating Schaffer collaterals ten times at 10 Hz ( Figure 5C ). NFA did not alter the AMPA-fEPSPs (106% ± 8.4%, n = 7, p = 0.8). 100 mM NFA also did not alter the pharmacologically isolated NMDA-EPSCs recorded from individual CA1 pyramidal neurons (101% ± 3.1%, n = 5, p = 0.2; Figure 5D ) (external Mg 2+ was removed to facilitate NMDA receptor activation, and 10 mM internal Cl À was used to minimize the driving force for Cl À ions when E Cl is À64.4 mV and holding potential is À65 mV). Thus, blocking CaCC alters the action potential waveform in the soma without altering transmitter release, indicating that functional CaCCs reside in somatodendritic regions but not the nerve terminals of CA3 pyramidal neurons. Figure 5E , blocking CaCC with NFA reduced the NMDA-EPSC by 28% ± 4.3% (n = 10, p < 0.05), indicating that CaCC is in the vicinity of NMDA-Rs to be activated by the Ca 2+ influx through NMDA-Rs. Importantly, when 10 mM of BAPTA was included in the 130 mM Cl À internal solution, NFA no longer had effect on NMDA-EPSC (100% ± 1.4%, n = 10, p = 0.13; Figure 5F ), providing further evidence that NFA has no presynaptic effect on transmitter release. In contrast, when we included 10 mM EGTA in the patch pipette solution with 130 mM Cl À , 100 mM (B) Quantitative RT-PCR revealed that 16B-shRNAs #2 (left) and #5 (right) reduced the expression of TMEM16B mRNA to 54% ± 1.0% (n = 3) and 37% ± 5.5% (n = 3) of scrambled shRNA control respectively. *p < 0.05. See Figure S3C for additional control for knockdown of TMEM16B expression by 16B-shRNA #2 and #5. (C) CaCC tail current from cultured hippocampal pyramidal neurons at room temperature is significantly reduced (by 67.5%) by TMEM16B shRNA knockdown (red), but not by scrambled RNA control (black). Inset (top left): TMEM16B knockdown does not affect the Ca 2+ current.
(D) Ca 2+ -activated Cl À current is reduced by 60% ± 4.5% and 61% ± 5% by TMEM16B shRNA #2 and #5, respectively (scrambled, n = 17, shRNA #2, n = 18, p < 0.01, shRNA #5, n = 12, p < 0.01, 12 days after infection).
(E) Left, TMEM16B shRNA #2 knockdown broadens spike waveform (red) as compared to scrambled RNA control (black) (12 days after infection). Right, summary of the effect of TMEM16B-shRNA #2 and #5 on action potential duration (resting potential $65 mV).
(F) In neurons recorded (with $140 mM Cl À on both sides) at 35 C 10 days after infection with lentivirus for scrambled shRNA (top panels), raising intracellular Ca 2+ from 0 (left) to 0.5 mM Ca 2+ (right) gives rise to CaCC that is blocked by 300 mM NFA. This CaCC current was greatly reduced in neurons infected with shRNA #5 (middle panels). Current-voltage curves (bottom panels) plotted for current recorded by applying voltage steps from À80 to +80 mV (10 mV intervals) from holding potential of 0 mV (E Cl = 0) without intracellular Ca 2+ (left, bottom) and with 0.5 mM intracellular Ca 2+ (right, bottom), show that 16B-shRNA #2 and #5
reduced CaCC in hippocampal neurons by $80% at positive voltages. *p < 0.01.
NFA still reduced NMDA-EPSC by 32 ± 9% (n = 5, p < 0.01; Figure 5G) . As summarized in the histogram ( Figure 5H ), Ca 2+ influx through NMDA-Rs is capable of activating CaCCs that are in close proximity so that the slower Ca 2+ chelator EGTA, but not the fast Ca 2+ chelator BAPTA, allows CaCC activation for feedback modulation of NMDA-EPSCs.
To explore the physiological contribution of CaCCs, first we performed field recording of the pharmacologically isolated NMDA-fEPSP in the CA1 dendritic field in the presence of 2.5 mM Ca 2+ and 1.3 mM Mg 2 . During a 10 Hz stimulation of Schaffer collaterals, the NMDA-fEPSPs gradually increased ( Figure S5 , left). Bath application of NFA enhanced the third, sixth, and tenth (n = 8; third, 138.4% ± 1.5%, p < 0.01; sixth, 145% ± 6.6%, p < 0.01; tenth, 140 ± 6.4%, p < 0.01) but not the first NMDA-fEPSP (105% ± 0.5%, n = 8, p = 0.8) ( Figure S5 , right), indicating that only when consecutive synaptic responses cause sufficient Ca 2+ buildup for CaCC activation does NFA exert an effect on the synaptic response. Next, we recorded the pharmacologically isolated NMDAEPSPs in CA1 pyramidal neurons while stimulating Schaffer collaterals at 10 Hz and asked whether CaCC plays a role in NMDA-EPSP-spike coupling. In the presence of 10 mM internal Cl À , 100 mM NFA enhanced NMDA-EPSP-spike coupling; NMDA-EPSPs summate to spike much later (first spike occurring most frequently at the tenth synaptic response) when CaCC is intact than when CaCC is blocked by 100 mM NFA (first spike occurring most frequently at the fourth or fifth responses) (Figure S6A) . Thus, when CaCC is blocked by NFA, neurons fire spikes more readily with reduced average latency to first spike and increased average number of spikes per train ( Figure S6B ; n = 10, p < 0.001).
The CaCC function depends on the Cl À concentration gradient because when we elevated the internal Cl À level to 130 mM (E Cl $0 mV), reducing CaCC with 100 mM NFA delayed spike initiation, increased the average latency to first spike and reduced the average number of spikes generated (Figures S6C and  S6D ; n = 10, p < 0.001). Thus, whereas CaCC normally acts as an inhibitory brake on NMDA-EPSP to spike coupling, elevating internal Cl À concentration during neuronal activity or dysfunction could cause CaCC to provide positive feedback and enhance excitation.
CaCC Provides a Brake to the Excitatory Synaptic Response, Temporal Summation, and EPSP-Spike Coupling under Physiological Conditions at 35 C To further explore the physiological contribution of CaCCs to synaptic responses, we stimulated Schaffer collaterals at 100-200 microns from the CA1 pyramidal cell body layer every 30 s and recorded from CA1 pyramidal neurons at 35 C in physiological solution plus picrotoxin to block GABA A receptors. Reducing CaCC with 100 mM NFA increased the amplitude of large but not small synaptic potentials ( Figure 6A ), most likely because the former involved NMDA receptor activation. Indeed, in the presence of 100 mM APV to block NMDA receptors, the EPSP was no longer affected by 100 mM NFA (Figure 5I ), regardless the stimulus intensity ( Figure 5J) ( Figure 6B , right panel). These controls reinforce the notion that the NFA block of CaCC affects the large synaptic potentials that involve activation of NMDA-Rs (6 mV EPSP: 147% ± 2.9%, n = 10, p < 0.05).
To test whether CaCCs also play a role in EPSP summation to regulate synaptic integration, we delivered 3 nerve stimuli at 40 Hz. Using the ratio of the third EPSP over the first EPSP as a measure of the efficacy of EPSP summation, we observed that reducing CaCC with 100 mM NFA enhanced the summation efficacy by increasing the size of the larger EPSPs (third EPSP) while leaving the first EPSP (EPSPs % 2 mV) unchanged (Figure 6C ). While reducing CaCC with 100 mM NFA enhanced EPSP summation under physiological conditions with 10 mM Figure 6D , middle panel). NFA had no effect on EPSP summation when BAPTA was included with 10 mM [Cl À ] in to chelate Ca 2+ ( Figure 6D , right panel). These controls reinforce the conclusion that CaCC modulates synaptic input integration in hippocampal neurons.
Lastly, to test whether CaCCs contribute to EPSP-spike coupling, we applied five nerve stimuli at 40 Hz. Using nerve stimulation that generated EPSPs too small to reach threshold for spike initiation even with temporal summation in control conditions ( Figure 6E , control, black), we found that reducing CaCC activity with 100 mM NFA enhanced EPSP-spike coupling and helped neurons to reach threshold for spike firing ( Figure 6E (Table 1) by raising the threshold for spike generation by EPSP under physiological conditions, whereas with elevated internal Cl À CaCC acts to reduce the threshold instead (Table 1) . Taken together, these studies show that CaCC normally acts as an inhibitory brake on action potential duration, EPSP size, EPSP summation as well as EPSP-spike coupling ( (Figure 2) . (3) The tail current is blocked by two structurally distinct CaCC blockers, NFA and NPPB ( Figure 3A) . (4) This tail current is greatly reduced by shRNA knockdown of TMEM16B, which encodes a CaCC ( Figures 4C and 4D) . (5) shRNA knockdown of TMEM16B also eliminates the bulk of the outwardly rectifying, NFA-sensitive, Ca 2+ -activated Cl À current of hippocampal neurons ( Figure 4F ). Notwithstanding the presence of CLC-3 voltage-gated Cl À channels that require CaMKII for activation in immature hippocampal neurons (Wang et al., 2006) , we found spike broadening by CaCC blockers with or without the CaMKII inhibitor KN62, suggesting that the CaCC control of hippocampal neuronal spike waveform is attributable to TMEM16B, but not CLC-3. Given that shRNA knockdown led to partial removal of TMEM16B, the tail current, and CaCC ( Figures 4B-4F ), it remains possible that CaCC channel proteins other than TMEM16B also contribute to hippocampal CaCC. Our finding of action potential broadening in hippocampal pyramidal neurons treated with the CaCC blocker NFA or ] in pipette solution, 100 mM NFA (red) reduces NMDA-EPSC (black) by 32% ± 9% (n = 5, p < 0.01). Blue, 100 mM APV applied at the end of the experiment. See Figure S1V for time course plot. (H) CaCC contributes to NMDA-EPSC when there is maximal driving force for Cl À (E, n = 10, p < 0.05) and when there is Ca 2+ influx through NMDA-Rs (G, n = 5, p < 0.01). Unlike BAPTA that quickly chelates Ca 2+ (F, n = 10), the slow Ca Figure S6 for NFA effect on pharmacologically isolated NMDA-EPSP-spike coupling.
The error bars are SEM.
Neuron
Hippocampal CaCC Modulates Neuronal Signaling NPPB, or shRNA to knock down TMEM16B, suggests that CaCC shortens spike duration, similar to BK channels (Adams et al., 1982; Lancaster and Nicoll, 1987; Storm, 1987a Storm, , 1987b . Interestingly, whereas BK channels regulate transmitter release most likely due to their control of spike waveform in the nerve terminal, blocking CaCCs does not affect transmitter release, indicating a paucity of active CaCCs in the axon terminals. Importantly, Ca 2+ influx through NMDA-Rs also activates CaCCs, which provide a brake to excitatory synaptic responses, analogous to the actions of the SK type of Ca 2+ -activated K + channels. These findings suggest that CaCCs in somatodendritic regions of hippocampal pyramidal neurons are involved in adjusting the extent of synaptic excitation and controlling the waveform of the action potential. How could CaCC in hippocampal neurons have escaped notice for so long? Cation channels are the focus of extensive analyses of action potentials in hippocampal neurons, from in vivo recordings half a century ago (Kandel and Spencer, 1961) to recent studies (Bean, 2007) . Involvement of Cl À channels was deemed unlikely early on because impaling neurons with KCl-filled electrodes leads to a reversal of inhibitory synaptic potentials without any obvious alteration of the action potential when compared to action potentials recorded with sharp electrodes containing potassium acetate (Storm, 1987a) . However, this differential sensitivity may have arisen from a difference in the acetate permeability of different Cl À channels (Bormann et al., 1987; Hartzell et al., 2005 current excitatory rather than inhibitory-the CaCC blocker has opposite effects on the action potential and synaptic potentials. Furthermore, inclusion of 10 mM BAPTA to chelate internal Ca 2+ and prevent CaCC contribution abolished the effect of the CaCC blocker. These control experiments confirm that the observed effects of the CaCC blocker are indeed dependent on both Ca 2+ and Cl À . Taken together with the fact that the CaCC blocker had no effect on the resting potential and input resistance of hippocampal neurons, these pharmacological studies provide evidence for CaCC modulation of several physiological functions in hippocampal neurons discussed below. Action potentials induced by 2 ms current injection under physiological conditions were broadened by blocking CaCC with 100 mM NFA while the voltage threshold remained unchanged (Table 1 )-as expected since the brief current injection would not have caused sufficient activation of Ca 2+ channels and CaCC to alter the threshold, whereas elevating internal Cl À caused the CaCC blocker NFA to narrow the action potential instead of widening it, also without altering the threshold (Table  1) . These experiments further illustrate the flexibility of CaCC modulation as the internal Cl À level changes with neuronal activity. Blocking CaCC enhanced the large but not small EPSPs under physiological conditions (Table 1 )-because NMDA receptor activation requires sufficient depolarization. Moreover, CaCC activity reduced EPSP summation and raised the threshold of action potentials elicited by stimulating presynaptic axons (Table 1) . In contrast to brief depolarization via current injection, EPSPs of sufficient size to approach threshold would have activated NMDA receptors to open CaCC channels that in turn would influence the spike threshold. Whereas under physiological conditions CaCC acts as a brake to reduce excitatory potential and raise the threshold for synaptic potentials to trigger spike generation, CaCC modulation could change qualitatively-to exaggerate the impact of excitatory synaptic inputs -if the Cl À driving force is altered by neuronal activity.
Possible Physiological Implications of CaCC Modulation of Action Potential Duration
Controlling action potential duration in different locations of a neuron has different physiological consequences. At the axon terminal, the spike duration dictates the amount of Ca 2+ influx and the resultant transmitter release (Hu et al., 2001; Lingle et al., 1996; Petersen and Maruyama, 1984; Raffaelli et al., 2004; Robitaille et al., 1993) . In the somatodendritic region, the spike waveform determines the firing pattern. We found that CaCCs control the duration of action potentials in the somatodendritic region but not the axon terminals of CA3 pyramidal neurons. Thus, unlike BK, CaCC modulates neuronal signaling by controlling the number of action potentials that can be generated by a burst of synaptic inputs without influencing the signaling strength of each action potential, namely its ability to trigger transmitter release. This finding also indicates that the spike waveform is likely not uniform throughout the neuron, as shown in previous studies (Geiger and Jonas, 2000) . What might be the physiological impact of CaCC modulation of action potential in the somatodendritic region? Given that the CaCCs are activated by Ca 2+ influx through NMDA receptors, CaCC likely exerts its influence over excitability in the somatodendritic region where an altered spike waveform impacts neuronal signaling in at least two possible ways: firing pattern and coincidence detection. Changing spike duration can alter the firing pattern, as in the case of BK channels (Madison and Nicoll, 1984; Shao et al., 1999) . Not only does the number of action potentials generated during a barrage of synaptic activities dictate the strength of the signal, the message conveyed also depends critically on the temporal pattern of spike firing. We have found that reducing CaCC activity could facilitate the EPSP-spike coupling, causing a short train of synaptic activities to transition from a single spike or no spike at all to a burst of action potentials, indicating that CaCC modulation could adjust neuronal signaling both quantitatively and qualitatively.
Action potentials can back-propagate into the dendrite of hippocampal pyramidal neurons (Hoffman et al., 1997; Migliore et al., 1999) . Modulation of the duration of back-propagating action potential invading the dendritic tree is likely to have a strong impact not only on dendritic excitability, but also on coincidence detection of synaptic inputs-the basis of synaptic plasticity. The relative timing between an incoming synaptic potential and a back-propagating spike can determine whether the synapse giving rise to the synaptic potential is potentiated or depressed (Caporale and Dan, 2008; Dan and Poo, 2004) . A broader spike could conceivably widen the time window during which a synaptic signal can be potentiated.
Implications of CaCC Modulation of EPSP Amplitude, EPSP Summation, and EPSP-Spike Coupling
This study provides evidence for the involvement of Ca 2+ -activated Cl À channels in the negative feedback to rein in the excitatory synaptic responses. Remarkably, NFA block of CaCC increased synaptic potentials in a way similar to the apamin block of SK channels (Ngo-Anh et al., 2005) . Reducing CaCC activity facilitates EPSP summation by leaving the earlier, smaller EPSP intact and amplifying the later, larger EPSPs ( Figure 6A ; Table 1 ). This activity-dependent modulation is more nuanced than simple EPSP modulation and has two important implications (1) CaCC only reins in large EPSPs that have the potential of bringing the neuron to firing an action potential; CaCC acts as a brake, but not on all EPSPs. (2) (Fiumelli et al., 2005; Woodin et al., 2003) . This activitydependent shift in the Cl À gradient will cause CaCCs to progressively lose their grip over the action potential duration and threshold for spike initiation by synaptic potentials, as well as EPSP amplitude and summation. Epilepsy patients exhibit upregulation of NKCC1 (Cl À accumulator) and downregulation of KCC2 (Cl À extruder) in the temporal lobe, resulting in a positive shift in E Cl (Palma et al., 2006) . In hippocampal slices, KCC2 undergoes downregulation after sustained interictal-like activity in zero-Mg 2+ conditions (Rivera et al., 2004) . Similar positive shift in E Cl due to altered Cl À gradient also takes place with brain trauma (Bonislawski et al., 2007) and axonal injury (Nabekura et al., 2002 
Primary Hippocampal Neuron Culture
Hippocampal neurons were isolated from embryonic day 17 C57BL/6 mouse brains, and plated at 2.5-3 3 10 4 cells per cm 2 on poly-L-lysine treated coverslips or culture dishes as described (Fu et al., 2007) .
In Situ Hybridization C57BL/6 mice (2-3 months old) were deeply anesthetized and then perfused with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) (pH 7.4) before removing the brain for further fixation in 4% paraformaldehyde/ PBS overnight. in situ hybridization was performed using a digoxigeninlabeled RNA probe complementary to the mouse TMEM16B mRNA, on 20 mm cryostat sections. See Supplemental Experimental Procedures for more details. MinElute Kit (QIAGEN) following the manufacturers' instructions. All the isolated RNA was used in a reverse transcription reaction to synthesize cDNA using the High Capacity RNA to cDNA Master Mix (Applied Biosystems).
RT-PCR and Quantitative RT-PCR
Quantitative PCR was performed with Power SYBR Green PCR Master Mix (Applied Biosystems) in the ABI 7900TH Sequence Detection PCR System (Applied Biosystems). Four microliters and 0.4 microliters of cDNA were used to amplified TMEM16B and an internal control GAPDH, respectively (Kimura et al., 2005) . Significance of the results was determined using Student's t test. See Supplemental Experimental Procedures for more details.
TMEM16B Antibody Generation
A rabbit polyclonal antibody was generated against an epitope of mouse TMEM16B protein (QLKEGTQPENSQFDQE) and affinity-purified with the immunizing peptide (Yenzym, South San Francisco, CA).
Protein Extraction and Western Blotting
Hippocampal cultures were lysed for 30 min in a lysis buffer (2% sodium dodecyl sulfate [SDS] , 100 mM dithiothreitol, Complete Proteinase Inhibitor [EDTA-free, Roche Applied Science], and PBS [pH 7.5]). Lysates were centrifuged at 16,000 3 g for 10 min. The supernatants were retained for SDS-polyacrylamide gel electrophoresis. Protein samples were resolved with 4%-12% polyacrylamide gels, and subsequently electroblotted to polyvinylidene fluoride (PVDF) membranes. Blots were incubated with primary antibodies overnight at 4 C, followed by incubation with HRP-linked secondary antibodies. Signals were visualized using ECL Plus reagent (GE Healthcare) and CL-XPosure Film (Thermo Scientific). The following primary antibodies were used: purified polyclonal rabbit anti-TMEM16B (1:500), mouse anti-a-tubulin (1:1,000, Sigma-Aldrich), mouse anti-b-tubulin (1:1,000, Covance), rabbit anti-DsRed (1:1,000, Clontech).
shRNA and Lentivirus Infection
The target sequences of TMEM16B-shRNA #2, 16B-shRNA #5 and scramble shRNA are 5 0 -GCCTCCATCTTGTTTATGATT-3 0 (clone TRCN0000 127010, Open Biosystems), 5 0 -GCCAGTCATCTGTTTGACAAT-3 0 (clone TRC N0000127013, Open Biosystems), and 5 0 -CCTAAGGTTAAGTCGCCCTCG-3 0 (Addgene plasmid 1864) (Sarbassov et al., 2005) , respectively. The shRNAs were cloned into pSicoR-GFP lentiviral transfer vector as described by Dr. Tyler Jacks laboratory (http://web.mit.edu/jacks-lab/protocols/pSico. html). Lentiviruses carrying the shRNAs were packaged and concentrated at the UCSF Sandler Center Lentiviral RNAi Core. Hippocampal cultures (10 5 cells at 4 DIV) were infected with lentiviruses expressing a scrambled shRNA, TMEM16B-shRNA #2 or #5. Tail current and action potential recordings were performed and compared between GFP-expressing neurons 8-12 days after infection. Total RNA was extracted 10 days after infection for quantitative RT-PCR analysis.
Electrophysiology
Hippocampal Culture Recording Whole-cell recordings were performed on individual cultured pyramidal neurons at 14-21 days in vitro. Pyramidal neurons were distinguishable by their relatively large size, lower input resistance (100-200 MU), and prominent apical dendrite. The recording pipettes were made from borosilicate glass capillaries (P-97 Sutter Instrument, 1.5 mm/0.86 mm) and pulled on the day of use (3-4 MU). All internal solutions have pH 7.2-7.4 and $300 mosm. All external solutions were made fresh the day of use and adjusted to pH 7.2-7.4 and $300 mosm (measured on the day of use). The bath was constantly perfused with fresh external solution at 2 ml/min throughout the recording, and all experiments were performed at room temperature. The neurons were visualized with a CCD camera (Hamamatsu 
